Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry

María E Ramos-Araque1,2, James E Siegler3, Marc Ribo4,5

  • 1Institute of Biomedical Research of Salamanca, Department of Neurology, Hospital Universitario de Salamanca, Salamanca, Spain.

BMC Neurology
|January 30, 2021
PubMed

Insights

Cryptogenic stroke in COVID-19 patients is common and linked to higher mortality. This study identifies predictors of cryptogenic stroke and its association with increased in-hospital death risk.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) presents a notable risk for stroke, often cryptogenic.
  • Understanding stroke etiology in COVID-19 patients is crucial for predicting outcomes.

Purpose of the Study:

  • To evaluate clinical predictors of cryptogenic stroke in COVID-19 patients.
  • To assess short-term functional outcomes and in-hospital mortality based on stroke etiology in a large multinational cohort.

Main Methods:

  • A multinational cohort study included 14,483 laboratory-confirmed COVID-19 patients with acute ischemic stroke (AIS) from 31 hospitals.
  • Clinical characteristics, stroke etiology, and in-hospital outcomes were analyzed for patients aged 18 years or older.

Main Results:

  • 1.1% of COVID-19 patients (156/14,483) had AIS. Cryptogenic stroke (42.6%) was the most frequent etiology.
  • Cryptogenic AIS was associated with higher white blood cell count, C-reactive protein, and D-dimer levels.
  • Cryptogenic stroke mechanism independently predicted a fivefold increase in in-hospital mortality (aOR 5.16), alongside older age and higher NIHSS.

Conclusions:

  • Cryptogenic stroke in COVID-19 patients is associated with a significant risk of early mortality.
  • Identifying cryptogenic stroke mechanisms is vital for managing COVID-19 patients at risk of stroke.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
124
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
133
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
92
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
114
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
288
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
262